Biofrontera Inc.
BFRIW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001858685
No open-market purchases or sales by Biofrontera Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $4.48K in total; no superinvestor holds it.
Other share classesBFRI
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −1 vs. previous quarter
- 5
- 13F valueReported value at the end of Q2 2026
- $4.48K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding BFRIW, Q2 2026
No superinvestor reported holding BFRIW at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Biofrontera Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 2025 (view filing) | Sep 16 | 2 days | Biofrontera AGDirector, 10% Owner | PPurchase | +4.83M | – | – | –3.02K after | Derivative |
Top 10 13F holders, Q2 2026
The largest institutional positions in Biofrontera Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bard Associates Inc | 154,900 | $4.17K | 0.00% | 00.0% | Unchanged |
| Clear Street Group Inc. | 9,044 | $243 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,100 | $33 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 1,000 | $27 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 342 | $9 | 0.00% | −1−0.3% | Reduced |